Factors affecting the arrival time of cerebrovascular disease patients at the Emergency Department of a Peruvian hospital;Factores asociados al tiempo de llegada de pacientes con enfermedad cerebrovascular al Servicio de Urgencias de un hospital Peruano

Revista de Neurologia

Volumn 39, Issue 6, 2004, Pages 508-512

  Lira Mamani, David ^a   Concha Flores, G ^a  

^a HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

Author keywords

Arrival time; Cultural factors; CVD; Emergency; Socioeconomic factors; Stroke

Indexed keywords

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; AGED; AMBULANCE; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CULTURAL FACTOR; EMERGENCY HEALTH SERVICE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT TRANSPORT; PERU; SCHOOL; SOCIAL ASPECT; SOCIOECONOMICS; STROKE; TIME;

EID: 8144227365     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3906.2004036     Document Type: Article

References (36)

1. Adams R, Victor M, Ropper A. Principios de neurología. 6 ed. México: McGraw-Hill Interamericana; 2001.
2. Castillo J, Zarranz JJ, Larracoechea J. Enfermedades vasculares cerebrales (EVC). In Zarranz JJ, ed. Neurología. Madrid: Elsevier Science; 2003. p. 357-435.
3. Uribe C, Arana A, Lorenzana P. Fundamentos de medicina. Neurología. Medellín: Corporación para Investigaciones Biológicas; 2001.
4. Deza L, Aldave R, Barrera J. Historia natural de la enfermedad vascular cerebral en el Perú. Rev Neuropsiquiatr 2001; 64: 105-32.
5. Handschu R, Garlin A, Heuschmann P, Kolomisnky-Rabas P, Erbguth F, Neundörfer B. Acute stroke management in the local General Hospital. Stroke 2001; 32: 866-70.
6. Thrift A, Dewey H, Macdonell R, Mcneil J, Donnan G. Incidence of the major stroke subtypes. Stroke 2001; 32: 1732-8.
7. Carod-Artal FJ, Egido-Navarro JA, Gonzáles-Gutiérrez JL, Varela de Seijas E. Coste directo de la enfermedad cerebrovascular en el primer año de seguimiento. Rev Neurol 1999; 28: 1123-30.
8. Carod-Artal FJ, Egido-Navarro JA, Gonzáles-Gutiérrez JL, Varela de Seijas E. Percepción de la sobrecarga a largo plazo en cuidadores de supervivientes de un ictus. Rev Neurol 1999; 28: 1130-8.
9. National Heart, Lung and Blood Institute. Fact Book Fiscal Year 1996. Bethesda: US Dept. of Health and Human Services, NIH; 1997.
10. Sánchez-Pérez R, Moltó J, Medrano V, Beltrán I, Díaz-Marín C. Aterosclerosis y circulación cerebral. Rev Neurol 1999; 28: 1109-15.
11. Andre-Peterson L, Engstrom G, Hagberg B, Janzon L, Steen G. Adaptative behavior in stressful situations and stroke incidence in hypertensive men. Stroke 2001; 32: 1712-20.
12. Mendes I, Baptista P, Soares F, Oliveira V, Ferro JM. Diabetes mellitus y estenosis intracraneales. Rev Neurol 1999; 28: 1030-3.
13. Gil de Castro R, Gil-Núñez AC. Factores de riesgo del ictus isquémico. Rev Neurol 2000; 31: 314-23.
14. Saposnik G, Terzaghi MA. Aspectos genéticos en la enfermedad cerebrovascular. Rev Neurol 1999; 28: 1098-104.
15. Morgenstern L, Staub L, Chan W, Wein T, Bartholomew K, King M, et al. Improving delivery of acute stroke therapy. Stroke 2002; 33: 160-6.
16. Kase CS. La Unidad de Ictus: pieza fundamental en el manejo moderno del ictus. Rev Neurol 2001; 32: 133.
17. Fuentes B, Díez-Tejedor E, Lara M, Frank A, Barreiro P. Organización asistencial en el cuidado agudo del ictus. Las unidades de ictus marcan la diferencia. Rev Neurol 2001; 32: 101-6.
18. Liu L, Ikeda K, Yamori Y. Changes in stroke mortality rates for 1950 to 1997 in Japan. Stroke 2001; 32: 1745-9.
19. Briggs D, Felberg R, Malkoff M, Bratina P, Grotta J. Should mild or moderate stroke patients be admitted to an Intensive Care Unit? Stroke 2001; 32: 871-6.
20. Tengs T, Yu M, Luistro E. Health-related quality of life after stroke. A comprehensive review. Stroke 2001; 32: 964-72.
21. Tovar JL, Álvarez-Sabin J, Armario P. Tratamiento del aumento de presion arterial en la fase aguda del ictus. Rev Neurol 1999; 29: 1271-6.
22. Ameriso SF. Tratamiento de la enfermedad cerebrovascular con anticoagulantes y antiagregantes plaquetarios. Rev Neurol 1999; 29: 1285-90.
23. Reed S, Cramer S, Blough D, Meyer K, Jarik J. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001; 32: 1832-40.
24. Katzan I, Sila C, Furlan A. Community use of intravenous tissue plasminogen activator for acute stroke. Stroke 2001; 32: 861-5.
25. Merino J, Silver B, Wong E, Foell B, Demaerschalk B, Tamayo A, et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 2002; 33: 141-6.
26. Derex L, Adeleine P, Nighoghossian N, Honnorat J. Factors influencing early admission in a French Stroke Unit. Stroke 2002; 33: 153-9.
27. Menon SC, Pandey D, Morgenstern L. Critical factors determining access to acute stroke care. Neurology 1998; 51: 427-32.
28. Harraf F, Sharma A, Brown M, Less K, Vass R, Kalra L. A multicentre observational study of presentation and early assessment of acute stroke. Br Med J 2002; 325: 6-7.
29. Wester P, Radberg J, Lundgren B, Peltonen M. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA. A prospective, multicenter study, for the Seek-Medical-Attention-in-Time Study Group. Stroke 1999; 30: 40-8.
30. Sempere A, Ferrero M, Tahoces M, Duarte J, Tabernero C, Cabezas C, et al. Efectos secundarios del tratamiento antitrombótico en la prevención secundaria de la enfermedad cerebrovascular. Rev Neurol 2000; 30: 5-7.
31. Sacco R, Boden-Albala B, Abel G, Lin I, Elkind M, Hauser A, et al. Race-ethnic disparities in the impact of stroke risk factors. Stroke 2001; 32: 1725-31.
32. Kothari R, Sauerbeck L, Jauch E, Broderick J, Brott T, Khoury J, et al. Patients awareness of stroke signs, symptoms, and risk factors. Stroke 1997; 28: 1871-5.
33. Williams L, Bruno A, Rouch D, Marriot D. Stroke patient's knowledge of stroke: influence on time to presentation. Stroke 1997; 28: 912-5.
34. Yoo S, Heller R, Levi C, Wiggers J, Fitzgerald P. Knowledge of stroke risk factors, warnings symptoms, and treatment among an Australian urban population. Stroke 2001; 32: 1926-30.
35. Kolominsky-Rabas P, Weber M, Gefeller O, Neundoerfer B, Heuschmann P. Epidemiology of ischemic stroke subtypes according to TOAST criteria. Stroke 2001; 32: 2735-40.
36. Molina C, Montaner J, Abilleira S, Arenillas J, Ribó M, Huertas R, et al. Time course of tissue plasminogen activator-induced recanalization in acute cardiometabolic stroke. Stroke 2001; 32: 2821-7.